According to The Heart Foundation, cardiovascular diseases claim more lives than all forms of cancer combined. That’s why we are committed to its prevention and treatment through both biopharmaceutical, and medical device and diagnostic development.

Chiltern has a team of cardiologists and medical directors who specialize in cardiovascular diseases — adding support and value to your project with their expertise and leadership. Working as a cross-functional group, the team collaborates with you to provide cardiovascular advice from medical, operational, regulatory and cost-efficiency perspectives. The relationships they foster with major cardiovascular thought leaders and research centers around the world allow them to provide deeper insights and strategic guidance, leading to better patient experiences, improved clinical outcomes and expedited regulatory approvals.

Over the last five years, Chiltern has conducted 141 cardiovascular studies.

Cardiovascular

Investigators
Patients
Countries

Cardiovascular Bio and Med Device

BIOPHARMACEUTICAL STUDIES
MEDICAL DEVICE & DIAGNOSTICS STUDIES
Indication Breakdown
(Hover for details)
Studies By Phase
(Hover for details)

Let us help you reach your program’s goals with a comprehensive range of collaborative services: